Daiichi Sankyo Company: Oncology-driven revenue growth and FX gains lifted results, but profit fell on higher costsQuartr·2 hours agoDSNKY+3.11%4568
Toyota Stock, SoftBank And Daiichi Sankyo Offer Reliable Japan Dividend IncomeSimplywall·Jul 27 at 10:13 AMTM-0.72%DSNKY+3.11%
Daiichi Sankyo Co., Ltd. - Sponsored ADR (OTCMKTS:DSNKY) Short Interest Up 1,183.6% in JulyMarket Beat·Jul 24 at 06:00 PMDSNKY+3.11%4568
Daiichi Sankyo’s Enhertu plus pertuzumab wins EU CHMP backing for first-line HER2+ metastatic breast cancerPUBT·Jul 24 at 06:01 AMDSNKY+3.11%4568
3 Japanese Dividend Stocks Paying Over 3% That Income Investors May Want To WatchSimplywall·Jul 22 at 04:14 PM72039984
Canon Stock And 2 Japanese Dividend Stocks Offering Steady IncomeSimplywall·Jul 18 at 12:02 AM4568SFTBY+8.89%
Toyota Stock And 2 Japanese Dividend Shares Offering Steady YieldSimplywall·Jul 12 at 04:07 PM77517203
Key facts: Wainua fails CV trial; Enhertu nears UK price dealTradingView·Jul 9 at 02:14 AMAZNAZN-1.13%
AstraZeneca Nears Enhertu Deal After 300 Million UK InvestmentGuruFocus·Jul 8 at 01:46 PMAZN-1.13%AZN
AstraZeneca Advances Rare Bone Disease Pipeline While Enhertu Expands In Europebenzinga_article·Jun 29 at 11:59 AMAZNAZN-1.13%
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors | AZN Stock NewsStockTitan·Jun 28 at 05:30 PMAZNDSNKY+3.11%
AstraZeneca’s Datroway wins EU CHMP backing for first-line metastatic TNBC usePUBT·Jun 29 at 01:04 AMAZNAZN-1.13%
